the aid library

LIST OPTIONS

Filter

2718

External Link

Sexually Transmitted Diseases Treatment Guidelines, 2015

Centers for Disease Control and Prevention (2015) CC

Download (845)

View PDF (1310)

Global AIDS Response: Country Progress Report Nigeria 2015

National Agency for the Control of AIDS (NACA); UNAIDS; Federal Ministry of Health, Nigeria (2015) C1

Download (251)

View PDF (242)

Statement to African Union Member States on the deployment of the AstraZeneca COVID-19 Vaccine to the continent and concerns about adverse event reports coming from Europe

African Union; Africa CDC Centres for Disease Control and Prevention; World Health Organization WHO, et al. (2021) CC

19 March 2021

Download (280)

View PDF (553)

The Core Elements of Human Antibiotic Stewardship Programs in Resource-Limited Settings

Centers for Disease Control and Prevention CDC (2018) C_CDC

Antibiotic stewardship refers to coordinated efforts and activities that seek to measure and improve use of antibiotics. Implementation of ASPs has demonstrated positive public health and clinical impacts including reducing costs, lengths of hospital stays, and the burden of antibiotic resistance wh... more

Download (223)

View PDF (348)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (315)

View PDF (384)

African Union AMR Landmark Report: Voicing African Priorities on the Active Pandemic

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2... more

Download (246)

View PDF (366)

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC

Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren... more

Download (26106)

View PDF (6700)

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1

3rd edition

Download (760)

View PDF (1022)

Antimicrobials use, reistance and containment baseline survey (Ethiopia)

Drug Administration and Control Authority of Ethiopia , et al. (2009) C1

Emergence of antimicrobial resistance is a result of the use, overuse and misuse of antibiotics both in humans and animals. In Ethiopia, there are indications on the misuse of antibiotics by health care providers’, unskilled practitioners, and drug consumers. These coupled with rapid spread of res... more

Download (329)

View PDF (442)

The Core Elements of Hospital Antibiotic Stewardship Programs: 2019

Centers for Disease Control and Prevention CDC (2019) C_CDC

This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti... more

Download (562)

View PDF (1251)

GOOD MANUFACTURING PRACTICE GUIDELINES FOR PHARMACEUTICAL PRODUCTS

National Agency for Food and Drugs Administration and Control (NAFDAC), Nigeria (2016) C2

Download (1306)

View PDF (3331)

Critical aspects of the safe use of personal protective equipment

European Centre for Disease Prevention and Control (2014)

A training tutorial for healthcare professionals This ECDC tutorial presents the fundamental concepts of personal protective equipment (PPE) and barrier nursing to support preparedness in hospitals across Europe. It provides practical information on the proper use of PPE at the point of care, inclu... more

Download (3704)

View PDF (2051)

Guidelines for Registration of Medicines and Health Products in Liberia

Liberia Medicines and Health Products Regulatory Authority (LMHRA) (2012) C1

Download (381)

View PDF (498)

Roundtable on Hospital Communications in a Mass Casualty Radiological Event

Centers for Disease Control and Prevention (CDC) (2003) C_CDC

On January 14-16, 2003, the Centers for Disease Control and Prevention (CDC) held a communications roundtable in Atlanta, Georgia, to explore hospitals' challenges in communicating with internal and external audiences in communitywide emergencies involving radioactive materials. The roundtable, Hosp... more

Download (288)

View PDF (400)

Communiqué du Centre Africain pour le Contrôle et la prévention des Maladies sur les remèdes et les médicaments à base de plantes

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

Les médecines traditionnelles à base de plantes ou phytomédicaments jouent un rôle important dans la gestion des maladies en Afrique et sont largement utilisées comme médecines alternatives. Il est donc important d'évaluer à la fois la sécurité et l'efficacité de ces actifs botaniques ind... more

Download (349)

View PDF (482)

A Guide to Operating Public Shelters in a Radiation Emergency

Ansari, Armin; Caspary, Kevin Centers for Disease Control and Prevention (CDC) (2015) C_CDC

This guide is intended for shelter operators, planners, and staff, as well as emergency managers, public health professionals, and radiation protection professionals who participate in shelter planning and could be called upon to support shelter operations. This guide provides information on the inc... more

Download (793)

View PDF (832)

Infection Prevention Checklist for Dental Settings

Centers for Disease Control and Prevention; US Dept. of Health and Human Services (2016) C1

Basic Expectations for Safe Care

Download (712)

View PDF (1825)

Target Product Profile (TPP) for the development of improved Cholera rapid diagnostic tests

Global Task Force on Cholera Control (GTFCC) World Health Organisation (WHO) (2017) C_WHO

The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ... more

Download (868)

View PDF (992)

Global AIDS Response: Country Progress Report Nigeria 2014

National Agency for the Control of AIDS (NACA); UNAIDS; Federal Ministry of Health, Nigeria (2014) C1

Download (206)

View PDF (342)

المراكز الأفريقية لمكافحة الأمراض والوقاية منها بيان حول العلاجات والأدوية العشبية Statement on herbal remedies and medicines for prevention and treatment of Covid-19

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1

تقوم الأدوية التقليدية أو الأدوية النباتية المعتمدة على الأعشاب بدور كأدوية بديلة. عليه، فإنه من المهم ٍ واسعٍم على نطاقَستخدُالأمراض في إفريقيا وتتقييم كلٍّ من س�... more